Describes the pharmaceutical pricing process, its business, economic and social challenges. The 3rd edition is significantly updated to reflect todayâ s environment. It will help a wide range of audiences, from healthcare industry professionals to policy makers, gain a better understanding of this complex field.
Describes the pharmaceutical pricing process, its business, economic and social challenges. The 3rd edition is significantly updated to reflect todayâ s environment. It will help a wide range of audiences, from healthcare industry professionals to policy makers, gain a better understanding of this complex field.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Ed Schoonveld has 30+ years of experience in pharmaceutical pricing and access. He is currently Managing Partner of the Value and Access Practice with ZS Associates. He led global pricing functions for Wyeth, Lilly and BMS and consulting practices in Cambridge Pharma/IMS and Analytica International.
Inhaltsangabe
List of Figures List of Tables List of Abbreviations Foreword by Andrea Mantovani Acknowledgements Preface About the Author Introduction Part A The Challenges of Drug Pricing and Market Access 1 Why is drug pricing different? 2 The Age of Value and Affordability 3 The Access Journey 4 Fair Pricing Part B Traveling the Access Journey 5 Payers 6 Medical Community 7 Provider Organizations 8 Patients Part C Pricing and Payer Management Techniques 9 Fundamentals of Pricing 10 Reference-Based Pricing 11 Health Economics and Outcomes Research 12 Attributes Benefits Value and Price Part D Structured Access and Pricing Approaches 13 Pricing and Drug Development 14 Payer Segmentation 15 The PODiUM Framework 16 BEST Framework 17 Development Options and Decisions 18 Value Story and Messaging Part E Developing an Integrated Global Strategy 19 Developing a Global Pricing Strategy 20 Public Policy 21 Oncology and Orphan Drugs 22 Gene Therapy Pricing and Funding 23 Biosimilars 24 Payer and Pricing Research Part F Access and Pricing Strategy Implementation 25 Organizing for Access 26 Access and Price Negotiations 27 Value-based Agreements 28 Creating Win-Win Deals Part G Key Health Care Systems 29 United States 30 Canada 31 France 32 Germany 33 Italy 34 Spain 35 United Kingdom 36 Japan 37 Australia 38 Brazil 39 China 40 India 41 South Korea References Index
List of Figures List of Tables List of Abbreviations Foreword by Andrea Mantovani Acknowledgements Preface About the Author Introduction Part A The Challenges of Drug Pricing and Market Access 1 Why is drug pricing different? 2 The Age of Value and Affordability 3 The Access Journey 4 Fair Pricing Part B Traveling the Access Journey 5 Payers 6 Medical Community 7 Provider Organizations 8 Patients Part C Pricing and Payer Management Techniques 9 Fundamentals of Pricing 10 Reference-Based Pricing 11 Health Economics and Outcomes Research 12 Attributes Benefits Value and Price Part D Structured Access and Pricing Approaches 13 Pricing and Drug Development 14 Payer Segmentation 15 The PODiUM Framework 16 BEST Framework 17 Development Options and Decisions 18 Value Story and Messaging Part E Developing an Integrated Global Strategy 19 Developing a Global Pricing Strategy 20 Public Policy 21 Oncology and Orphan Drugs 22 Gene Therapy Pricing and Funding 23 Biosimilars 24 Payer and Pricing Research Part F Access and Pricing Strategy Implementation 25 Organizing for Access 26 Access and Price Negotiations 27 Value-based Agreements 28 Creating Win-Win Deals Part G Key Health Care Systems 29 United States 30 Canada 31 France 32 Germany 33 Italy 34 Spain 35 United Kingdom 36 Japan 37 Australia 38 Brazil 39 China 40 India 41 South Korea References Index
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
